ARCHIVES

IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters

This article is from The Cancer Letter archive.

Vol. 38 No. 12 | March 23, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

October 21, 1988

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978

Protocols Approved By NCI

April 30, 2004

No Controversy Over Cancer Act This Time

May 25, 1990